β-lactams are the most widely used antibiotic family, but they are also the most common cause of drug-induced hypersensitivity reactions. The estimated prevalence of reported penicillin allergy ranges between 9% and 12%, although a high percentage of patients with a history of penicillin allergy have no subsequent reactions on reexposure to β-lactams. A self-reported penicillin allergy has been associated with antimicrobial resistance, increased cost, intensive care admission, and death, making it essential to establish an accurate diagnosis. In addition to a thorough clinical history, diagnostic methods include skin tests, in vitro tests, and drug-challenge tests. In this review, the diagnosis and management of patients with self-reported penicillin allergy is discussed, including the recently introduced antimicrobial stewardship strategy.
nonallergic patients, those wrongly labeled as al lergic to penicillin have a longer duration of hos pitalization and show increased rates of infec tions caused by Clostridium difficile, methicillin resistant Staphylococcus aureus, and vancomycin resistant Enterococcus. 14, 15 Therefore, an accurate and rapid diagnosis is crucial to improve the use of antibiotic therapy, increase patient safety, and reduce health care costs.
Recently, βlactam skin testing has been pro posed as an antibiotic stewardship strategy to ex clude immunoglobulin E (IgE)mediated allergy and promote the use of βlactam therapy in pa tients with reported allergy; in the case of the negative results of skin tests, a βlactam could be administered. [15] [16] [17] This recommendation is based on the high negative predictive value of skin tests reported by American studies in which bencylpenicillin and penicillin V were predomi nantly prescribed. 18 However, more recent Eu ropean studies reported that between 8.4% and 30.7% of patients with negative results reacted to drug challenge. 12, 13, [19] [20] [21] This is likely due to the fact that in Europe, especially in southern Eu rope, prescription and consumption of amino penicillins, amoxicillin/clavulanic acid (AXCLV), Introduction βlactams are the most widely used antibiotic family owing to their high safety pro file, broad spectrum of activity, and low costs.
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They also remain the most common cause of drug induced hypersensitivity reactions. 4 Penicillin al lergy is the most commonly reported drug aller gy, but its true prevalence in the general popula tion is unknown and is usually overestimated. 5, 6 It is estimated between 9% and 12%, 7,8 and may be as high as 15% in hospitalized patients.
9 How ever, a high percentage of patients with a history of penicillin allergy have no subsequent reactions on reexposure to penicillin or βlactam antibiot ics. 5, 6, [10] [11] [12] [13] This discrepancy is probably caused by multiple factors, including nonallergic adverse events, as for example cutaneous lesions may be part of the natural history of the disease for which antibiotics were prescribed. 13 βlactam allergy has considerable implications for public health. The selfreported penicillin al lergy has been associated with antimicrobial re sistance, increased cost, intensive care admis sion, and death.
14 Patients with a reported pen icillin allergy are more often treated with fluo roquinolones, clindamycin, vancomycin, glyco peptides, and aminoglycosides. Compared with
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Using βlactam antibiotics in patients with a history of βlactam allergy: current concepts Antigenic determinants of β-lactams Penicillins and βlactams are generally considered immuno logically haptens and need to bind to carrier mol ecules to acquire complete immunogenic poten cy. The binding of the antibiotic to amino groups of autologous proteins induces a conformational modification that causes the immune system to recognize them as strange. The βlactam rings and the side group are all potentially immunogenic.
Penicillins have been the most studied antibiot ics. The βlactam ring is intrinsically reactive and does not need prior metabolism. The instability of its structure makes it open quickly, allowing the carbonyl groups to form amidetype linkages with the amino groups of the lysine residues of the nearby proteins. 26 As approximately 95% of the penicillin molecules are bound to proteins in this manner, the antigenic determinant formed, benzylpenicilloyl (BPO), has been known as the major antigenic determinant of penicillin. BPO has been attached to a weakly immunogenic car rier molecule, called polylysine, to form benzyl penicilloyl polylysine (BPOPPL), which is used in making skin tests. The remaining part of the penicillin molecule degrades to a range of deriv atives which can also act as haptens. 27 These are minor determinants accounting for allergic reac tions in approximately 10% to 20% of patients. 23 The minor determinant mixture (MDM) has been also used in skin tests.
The progressive increase in the consumption of amoxicillin (AX) has led to an increase in the detection of patients allergic to AX who tolerate benzylpenicillin (BP). 28 These reactions are called selective reactions to AX. The major antigenic de terminant of AX is the amoxicilloyl amide, which results from the opening of the βlactam ring by amino groups. 29 Although the structure of the possible antigen ic elements of cephalosporins is not well known, different experimental studies have proved that they can generate structures able to provoke spe cific immune response. 30 IgE antibodies that re act with cephalosporins have been shown to de tect a wide range of specificities, although the fundamental antigenic part lies in the side chain R1 and part of the βlactam ring.
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Finally, considering the great variety of chemi cal structures susceptible to be formed within the βlactam antibiotics, the number of haptencarrier conjugates that can be generated and recognized specifically by the immune system is high.
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Thus, from a clinical point of view, patients can have: 1) selective reactions to a given compound; 2) reactions to different βlactam sharing an iden tical side chain, such as AX and cefadroxil; and 3) reactions to the nuclear region of the antibi otic, resulting in a crossreactivity between dif ferent βlactams.
Allergic reactions to β-lactam antibiotics Drug hy persensitivity or drug allergic reactions have been classified according to distinct criteria. Depend ing on the immunologic effector mechanism, the and cephalosporins is preferred.
2 As a result, ad verse events may occur at a higher rate in Europe an populations if only skin testing is used. There fore, an adequate allergy evaluation is necessary to exclude βlactam allergy. 13, [22] [23] [24] β-lactam antibiotics βlactam antibiotics are a class of broadspectrum antibiotics with a com mon chemical characteristic, that is, the presence of a 4component βlactam ring. Depending on their chemical structure, βlactams are grouped into 2 major classes, penicillins and cephalospo rins, and 4 minor classes, monobactams, car bapenems, oxacephems, and clavams.
Thus, the basic structure of penicillins consists of this βlactam ring associated with another thi azolidine ring of 5 components, which gives rise to the nucleus responsible for its biological ac tion, namely, 6aminopenicillanic acid (6APA). It has a side chain (R) associated whose variety de termines many of the antibacterial and pharma cokinetic characteristics of the different penicil lins (FIGURE 1) . The cephalosporin nucleus, namely, 7aminocephalosporanic acid (7ACA), is analo gous to the penicillin nucleus 6APA. In the case of 7ACA, the βlactam ring is fused to a 6mem bered dihydrothiazine ring, thus forming the ce phem nucleus. Cephalosporins have a side chain in C7 (R1) and different substitutions in C3 (R2) (FIGURE 1) . Variations in the chemistry of the C3 side chain affect the drug metabolism, whereas variations in the side chain at C7 alter the resis tance to βlactamases and broaden their antibac terial activity. Carbapenems contain a carbon dou ble bond in place of sulfur in the 5member thia zolidine ring, while monobactams comprise the βlactam ring without an attached 5 or 6mem bered sulfur ring. 25 O the drug may be required to exclude hypersensi tivity in a nonsuggestive history of drug hyper sensitivity or to establish a firm diagnosis in the context of a suggestive history with negative or nonconclusive allergy tests.
Medical history A detailed history plays a fun damental role in the evaluation of patients with suspected hypersensitivity to drugs. This is even more important when the exact nature of the structures that trigger the immune reaction is unknown. The medical history allows us to de termine whether the reaction was immediate or nonimmediate, according to the latency period between the administration of the antibiotic and the onset of symptoms. In general, anaphylax is and other immediate reactions like most urti carias or bronchospasms typically develop with in minutes after drug administration. Detailed information on the symptoms and their severi ty should be collected.
Another important parameter that should be obtained from the history is the previous tol erance to the suspected antibiotic or to other βlactam antibiotics, as well as any later expo sure with good tolerance to βlactam antibiotics, including the eliciting one. This can help us deter mine the antibiotic that sensitized the patient. In addition, the event of later tolerance to a differ ent βlactam would suggest a selective reaction. The history should also include other data such as all medications that the patient was taking at the moment of the reaction or the possibility of allergy to other drugs.
However, in many cases, the history can be im precise because the patients is examined many years after the reaction and they may have lost sensitivity to the antibiotic. Solensky et al 36 ana lyzed different studies and reported that the find ing of a positive result in an allergy test in pa tients with vague or nonsuggestive allergic reac tions was not unusual and may have accounted for up to 33% of the cases with positive skin test results. Thus, based solely on the medical histo ry, there might be a percentage of patients with false negative results who should be taken into account and who may react to the antibiotic on new exposure. In a study performed by our group, the medical history as a diagnostic tool showed a sensitivity of 69.8%, specificity of 82.3%, and negative predictive value of 88.7%. 37 Skin testing Skin testing has been used for the diagnosis of both immediate and nonimmediate reactions to βlactam antibiotics. Skin tests have proved to be an important means of predicting which patients are at risk of developing IgEme diated reactions. 22, 23 Skin tests are generally safe, but systemic reactions may occur, especially in patients with a previous history of anaphylaxis, of whom up to 8% could present an adverse re action.
38 Therefore, testing should be undertaken by professionals with the knowledge, experience, classic work of Coombs and Gell 1 classified reac tions into 4 different types (I-IV). Subsequent ly, some authors have proposed modifications of that classification, such as dividing type II into 2 subtypes 2 and type IV into 4 subtypes. 3,4 In ad dition, the fifth mechanism has been suggested in granulomatous diseases, driven by innate im munity or type 1 or type 2 cytokines. 5 Clinically, on the basis of the time of appear ance of the reaction after drug intake and for di agnostic purposes, hypersensitivity reactions to βlactams have been classified as immediate or nonimmediate/delayed. Immediate reactions oc cur within 1 to 6 hours after the last drug admin istration, whereas nonimmediate reactions may occur any time as from 1 hour after the initial drug administration. 24 Immediate reactions typically appear within the first hour after the first dose of a new course of treatment. They usually manifest as urticaria, an gioedema, conjunctivitis, rhinitis, bronchospasm, gastrointestinal symptoms, or as anaphylaxis or anaphylactic shock. Nonimmediate reactions typically occur after 1 or more days of treatment, with maculopapular exanthemas and delayed ur ticaria as the most common clinical manifesta tions. Therefore, regarding allergy to penicillins and other βlactams, when we attempt to bring those classifications together, different pictures can be found depending on the mechanisms, time interval, dosing, duration of treatment, and clin ical presentation (TABLE 1) . 4, 34 Diagnosis of β-lactam allergy In order to reach an adequate diagnosis, a comprehensive medical his tory is essential, followed by skin tests. In vitro tests can be used when available. However, since the medical history is often not reliable and the sensitivity of skin and in vitro tests is not opti mal, a controlled drug provocation test (DPT) may be required to establish the diagnosis.
The European Network for Drug Allergy has devised various diagnostic algorithms for the evaluation of immediate 23 and nonimmediate reactions. 35 Although with limitations, these algorithms, are still useful in the evaluation of patients with a history of allergy to βlactam antibiotics.
Immediate or immunoglobulin-E-mediated reac-
tions Immediate reactions to βlactam antibi otics can be assessed by different methods, al ways starting with a detailed medical history fol lowed by skin tests, determination of specific IgE, or controlled administration of the drug, or any combination thereof (FIGURE 2). Among the avail able tests, skin tests are considered the most use ful technique for establishing a diagnosis of hy persensitivity in immediate reactions. In vitro tests have lower sensitivity than skin tests, but in some instances, they can be useful in confirm ing the diagnosis. However, since the sensitivity of these tests is not optimal, even with a clearly positive history, a controlled administration of cephalosporins. 22, 23 The same happens with the use of βlactamase inhibitors, as in recent years, patients with selective hypersensitivity to clavu lanic acid have been reported. 41 Therefore, the study of immediate allergy to βlactam antibiot ics is now more complex owing to the wide pan el of βlactams prescribed today. The sensitivity and specificity of skin tests are difficult to determine because the diagnostic gold standard, that is, DPT, is not performed in all patients for ethical reasons, given the risks that this procedure entails. In our experience, in pa tients with a previous lifethreatening reaction, a 1/10 to 1/1000 dilution of skin test reactants is recommended.
The percentage of positive skin test results in patients with a clinical history of a βlactam al lergic reaction varies between 7% and 76%, ac cording to different studies. 10,13,42-45 The higher frequency of positive skin test results is report ed in patients with very suggestive histories of immediate reaction, such as urticaria and ana phylaxis, and also when skin tests are made just a short time after the reaction has occurred, be cause a long interval between the reaction and skin testing reduces the likelihood of a positive response. 22, 46 and training to interpret test results and the abil ity to manage severe allergic reactions.
Skin tests are usually performed using the skinprick technique, by pricking the skin with an appropriate needle through an allergen solu tion. If this does not cause a reaction, an intra dermal test can be performed by the injection of 0.02 to 0.05 ml of the drug solution.
In the case of allergy to βlactams, commer cial preparations are available for skin testing, and these have been modified over time. Until 2013, the haptens used were the major determi nant of BP, BPOPPL, and MDM composed of BP, benzylpenicilloate, and benzylpenilloate. At pres ent, BPO is maintained as the major determinant, in this case conjugated to octalpolylysine, and a single minor determinant, benzylpenilloate, not present in the remaining smaller determinants described due to their high instability. 39 In ad dition, Romano et al 40 reported a small percent age of βlactam allergic patients (<5%) who test ed negative for BPOPPL and MDM, but positive for BP, recommending the inclusion of BP in the battery of skin tests.
At present, due to the changing patterns of βlactam use, and the appearance of sidechain specific reactions, it is necessary to use other determinants, such as AX or some history of lifethreatening reactions. 54 Moreover, this diagnostic tool can be used to find alterna tives to the culprit drug and to assess tolerance to potentially crossreactive drugs. 55 Immunoassays IgEmediated allergy to βlactams is diagnosed with antibodybased immunoassays that use several solid phases (agarose, cellulose discs), carrier molecules (human serum albumin, polylisine), and different determinants (BP, AX, and cephalosporins). Today, the ImmunoCAP system (ThermoFisher, Uppsala, Sweden), which works by a high surfacecapacity solidphase as say using a secondary fluorolabeled antibody, re mains the most widely used commercial method for diagnosing βlactam allergy. The specificity of this method ranges from 83.3% to 100%, and sen sitivity-from 12.5% to 25%. 56 Basophil activation test The basophil activation test has been used as a diagnostic test for IgEmediat ed reactions and is based on the quantification of different activation or degranulation markers on the basophil surface after stimulation by the cul prit drug. 57, 58 Several studies have analyzed the value of the test in the diagnosis of IgEmediat ed reactions to βlactams. The first studies using the basophil activation test to analyze βlactam allergy reported a sensitivity of 50% in patients who tested positive for at least 1 penicillin in a skin test and a specificity of 93%. 59, 60 Similar data were obtained in a multicenter study, 61 which re ported a sensitivity of 50% and a specificity be tween 89% and 97%, and emphasized the need to test more than 1 βlactam at a minimum of 2 concentrations to obtain optimal results.
Nonimmediate reactions The European guide lines 22, 35, 62, 63 suggest evaluating nonimmediate reactions to βlactam by both patch tests and in tradermal tests with delayed readings. The sen sitivity of skin tests in nonimmediate reactions is lower than that of immediate reactions. 22, 35 Patch tests are considered to be safer and to be the first step in the evaluation of severe cutane ous reactions. 62 A greater sensitivity for the intradermal test compared with patch tests in diagnosing non immediate reactions has been reported. 64 It has been described that the overall sensitivity of delayed reading skin tests may have been im proved using the combination of intradermal and patch tests.
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Drug provocation tests This procedure is important in nonimmediate reactions for which skin tests sensitivity is low. 22 However, DPTs should never be performed in patients who have experienced severe reactions such as vasculitis syndromes, ex foliative dermatitis, erythema multiforme major/ Stevens-Johnson syndrome, druginduced hyper sensitivity syndrome/drug reaction with eosino philia and systemic symptoms, and toxic epider mal necrolysis. 54 BPOPPL, the major determinant of penicillin, has been historically the most relevant. The first studies reported positive results in more than 70% of patients. 47, 48 The use of the MDM has been also considered important, as some studies suggested that 10% to 20% of patients with penicillin allergy tested positive for these determinants and nega tive for BPOPPL. 23 However, since the 1990s, the sensitivity of penicillin skin tests using BPOPPL and MDM has been progressively declining. 28 It is likely due to the decreasing use of parenteral pen icillin and the increased use of semisynthetic pen icillins, such as aminopenicillins and cephalospo rins, leading to an increase in the number of pa tients with selective sidechainspecific allergic reactions. 28, 49, 50 In the 1990s, the percentage of positive skin test results with AX or ampicillin in patients with penicillin allergy ranged from 26% to 47.5%. 28, 49 In a recently published series, we found that 36% of patients tested positive only for AX. 13 The de scription of selective reactions to clavulanic acid has highlighted the need to include this drug in the diagnostic workup. 41 Despite using a large panel of βlactams, the sensitivity of skin tests is not optimal. 23, 51 In ad dition, their sensitivity seems to have been de creasing in recent years, with a significant per centage of patients requiring DPTs for diagno sis. 21 It is also important to emphasize that in immediate reactions to βlactams, the sensitivi ty of skin tests decreases over time. Prospective studies have confirmed that skin test reactivity is lost over time in penicillinallergic patients, with only 30% to 50% of patients with initial positive results remaining positive after 5 years 46 ; the per centage of loss is even higher in the case of ami nopenicillins. 46 It is unknown what percentage of patients becomes positive again after a new expo sure to a βlactam, a phenomenon known as re sensitization. Several studies have indicated that between 1% and 27.9% of patients may be resen sitized after βlactam administration. 11,13,44,52,53 For this reason, in patients with a clear history of an immediate reaction after the administration of a βlactam derivative, who show negative results in skin and in vitro tests and good tolerance to a DPT, a reevaluation after 1 month is strongly rec ommended, 13, 23, 24 particularly if the reaction oc curred more that 1 year earlier.
Drug provocation tests DPTs are based on the con trolled administration of increasing doses of the drug to a patient with a history suggestive of drug allergy. This can be either the suspected culprit or an alternative structurally or pharmacologi cally related drug. Briefly, a DPT is usually per formed in a singleblinded procedure in patients with negative skin and in vitro test results. Esca lating doses of the drug are typically given at in tervals of 30 to 90 minutes until the full thera peutic dose is reached. 54 If symptoms appear dur ing the DPT, the procedure must be stopped. This procedure is not recommended in patients with a as cephalothin, cefamandole, and cephaloridine (TABLE 2) . In contrast, they do not react or scarce ly react with cephalosporins whose side chains have a different structure, such as cefuroxime and cefotaxime.
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The situation is similar for crossreactivity to cephalosporins in patients with selective sen sitization to aminopenicillins. Crossreactivity studies performed with the first, second, and third generation cephalosporins carrying differ ent side chains in patients allergic to BP or with selective sensitization to AX have not demon strated crossreactivity 71 or a very low frequen cy (around 3%) of crossreactivity. 72 On the con trary, the crossreactivity of AX with aminocepha losporins which have an identical side chain rang es from 14% to 38% for cefadroxil 73, 74 and around 30% for cephalexin. 75 However, the lack of complete crossreactivity indicates that, in addition to the side chain, oth er structures of the molecule of both βlactams are important for recognition by IgE antibodies. Thus, in a study of 128 patients allergic to peni cillin, 14 had positive skin test results for cepha losporins, and 4 of them had different patterns of reactivity with cephalosporins that could not be explained by the similarity of side chains or by the identity of the βlactam ring. 72 For this reason, it may be risky to treat penicillinallergic patients with cephalosporins based only on the side chain structure, without performing an al lergy study first.
With respect to T-cellmediated delayed hyper sensitivity to penicillins, the frequency of posi tivity in cephalosporin studies ranges from 2.8% to 31%.
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Cross-reactivity between cephalosporins Studies of the crossreactivity between cephalosporins are much less numerous but have shown that crossreactivity is largely based on the similarity of the R1 side chain chemical structure. 29 In con trast, the R2 side chain is unlikely to contribute to the formation of its antigenic determinants and to crossreactivity because this chain is frag mented and lost during the cephalosporin deg radation process.
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Studies have shown that around 50% to 60% of cephalosporinallergic patients are allergic to a single cephalosporin, while the remaining patients react to several different cephalospo rins. 33, 78 In most patients, the reactivity can be ex plained by the presence of identical R1 side chains, such as ceftriaxone, cefotaxime, and cefepime, Lymphocyte transformation test The lymphocyte transformation test is the most common in vi tro test for assessing specific cellular sensitiza tion. 66, 67 It has been used to diagnose βlactam allergy and has shown variable sensitivity (rang ing from 25% to 79%) for a nonimmediate allergic reaction to penicillin. [66] [67] [68] However, false positive results were reported in nonreactive patients who had been recently exposed to drugs. 67
Cross-reactivity Cross reactivity between penicillins Crossreactivity between drugs is due to the existence of antibodies or cells that recog nize an identical or similar structure present in different drugs. In clinical practice, it represents the risk of developing allergic reactions to relat ed drugs in patients who had a previous reaction to a single βlactam.
Regarding penicillins, there are 2 major groups of allergic patients: nonselective and selective re sponders. Nonselective responders are sensitized to the whole penicillin group because they have IgE antibodies that recognize the common de terminants of BP (BPOPPL and MDM). Selec tive responders have positive skin test results for semisynthetic penicillins, especially AX, neg ative skin test results for BP determinants, and tolerate the administration of BP. The frequency of each group has varied over time, as the use of AX has increased. According to different studies, the frequency of selective responders to AX can vary from 40% 13, 28 to almost 80% of patients. 41 It has been reported that up to 22% of patients with AX-CLVselective reactions are selectively al lergic to clavulanic acid and tolerate AX and BP. 41 Cross reactivity between penicillins and cephalosporins There have been numerous studies of cross reactivity between penicillins and cephalospo rins. Most of them were performed in patients allergic to penicillins and evaluated cephalospo rin sensitization. Studies published before 1980 found a high degree of crossreactivity, up to 60%, between BP and firstgeneration cephalo sporins, due to the similarity of the side chain in R1 or perhaps to contamination of the first cephalosporin preparations with traces of pen icillin. 69 Subsequent studies have shown much lower crossreactivity. These studies have re vealed the importance of the similarity of side chains for the degree of crossreactivity between penicillins and cephalosporins. Thus, antiBPO antibodies react with cephalosporins having a similar chain in position R1 to that of BP, such with ceftazidime has been described, as the R1 side chain is the same in both drugs. 94 Conclusions βlactams are antibiotics associat ed with a hihgher rate of adverse immune reac tions. This fact is associated with a clear overdi agnosis of allergy to βlactams. The fear of devel oping severe allergic reactions precludes the use of these antibiotics in patients that would clear ly benefit from them, which usually implies low er treatment effectiveness and a higher incidence of adverse reactions. The diagnosis of βlactam allergy relies on a comprehensive medical histo ry, skin tests, in vitro tests, and, when indicat ed, DPTs. Nowadays, skin tests and specific IgE have demonstrated to be useful tools in the di agnosis of immediate hypersensitivity reactions to βlactams. Nevertheless, their sensitivity and specificity are insufficient, and DPTs may be nec essary in up to 30% of patients.
In this context, in the setting of presumably al lergic patients without a confirmed positive diag nosis urgently requiring a βlactam antibiotic, the so called antimicrobial stewardship programs are being developed. In the case of βlactams, these programs are based on skin testing with βlactam in patients with suspected βlactam allergic reac tions and, if negative, the administration of a full dose of the βlactam. Although this could be an interesting approach, we believe that the sensi tivity and specificity of skin tests with βlactam are not high enough to use skin tests in this way. Moreover, there is a possibility of developing aller gic reactions when performing skin tests and also during the administration of the full dose of the drug. Therefore, we believe that an appropriate al lergy study, including a full battery of βlactam de terminants and a controlled challenge by trained staff is safer and has the advantage of provid ing accurate information about crossreactivity.
or very similar side chains, such as cefuroxime, ceftazidime, and the 3 cephalosporins mentioned above (TABLE 2) . 33, 46, 79 However, other studies have shown that the risk of developing a reaction does not depend only on the structural similarities be tween the side chains; therefore, an allergy test should always be performed before the adminis tration of another cephalosporin. 80, 81 Cross-reactivity with carbapenems Crossreactivi ty between penicillins and carbapenems is rare. Recent crossreactivity studies have shown a fre quency of around 1%, much lower than that in earlier publications. [82] [83] [84] [85] In one of the largest se ries, 212 adults allergic to penicillin showed neg ative skin test results for imipenem-cilastatine, meropenem, and ertapenem. All patients except one tolerated a carbapenemchallenge test, which showed negative results. 86 Crossreactivity be tween cephalosporins and carbapenems is also low: 1% for meropenem and 2% for imipenem. 87 In nonimmediate reactions, the reported frequen cy ranges from 0% to 5% according to different studies. [88] [89] [90] There have been very few studies evaluating crossreactivity between different carbapenems. Most publications are isolated cases in which tol erance to a different carbapenem was demonstrat ed. NogueradoMellado et al 91 described 2 pa tients with delayed hypersensitivity to carbapen ems. One of the patients developed a micropap ular rash with imipenem. Intradermal skin tests showed positive results for imipenem in delayed reading, but negative for meropenem. In addition, the patient tolerated meropenem. The second pa tient developed a generalized desquamative rash with mucosal involvement during treatment with meropenem. The intradermal test result was pos itive for meropenem but negative for imipenem, and the patient tolerated imipenem. The lack of crossreactivity between imipenem and merope nem in these 2 patients suggests that side chains, which are different, may play an important role in antigen recognition. 91 A case of anaphylactic reaction to imipenem--cilastatin has also been reported, with posi tive skin test results and specific IgE for imipen em-cilastatin, and negative for meropenem and cilastatin. 92 No cases of selective sensitization to cilastatin have been reported.
Cross-reactivity with monobactams Patients with immediate or delayed allergy to penicillins usu ally tolerate the administration of aztreonam.
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In a study of 16 patients with cystic fibrosis al lergic to semisynthetic penicillins, 1 patient was found to have positive skin test results for az treonam. However, it cannot be excluded that it could have been cosensitization, since they were patients who had received repeated treatments with aztreonam. 93 With regards to cephalospo rins, up to 3% of patients have positive skin test results for aztreonam. 87 A case of crossreactivity
